Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-05-26 18:00:38 ET · period of report 2026-05-21 · accession 0001235644-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 18:00 | 2026-05-21 | BBNX | MICHEL GERARD J | Dir | A - Grant | $0.00 | +17.0K | 33.5K | +103% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | A | A | 16,965 | $0.00 | 33,509 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. |